Winton Capital »

Milestone Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 14k 1.34

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Milestone Pharmaceuticals

Rtw Investments
Propel Bio Management
Point72 Asset Management
Simplify Asset Management
Millennium Management
Two Sigma Investments
Marshall Wace
Kalehua Capital Management
Lion Point Capital
Toronto-Dominion Bank
Morgan Stanley
Ameriprise Financial
Boxer Capital Management
UBS Group
Boothbay Fund Management

View all funds holding Milestone Pharmaceuticals